0 items

in your cart

Prescription Drug Search

Strengths available for Lamivudine solution:

Lamivudine solution 10mg/mL

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Lamivudine:

  • Algeria
  • Austria
  • Bahrain
  • Belgium
  • Bermuda
  • Brazil
  • Bulgaria
  • Cook Islands
  • Croatia
  • Cuba
  • Dominican Republic
  • Ecuador
  • El Salvador
  • European Union
  • Fiji
  • Finland
  • Georgia
  • Germany
  • Gibraltar
  • Greenland
  • Guatemala
  • India
  • Italy
  • Jordan
  • Korea, Republic of
  • Kuwait
  • Latvia
  • Monaco
  • Netherlands
  • Poland
  • Russian Federation
  • Saint Lucia
  • Saudi Arabia
  • Slovakia
  • Sri Lanka
  • Sweden
  • Thailand
  • Tunisia
  • United Kingdom, UK
  • United States, US
View All Countries

Latest news releases on Lamivudine:

HBV-related Decompensated Cirrhosis: Lamivudine vs Entecavir - Medscape News

Background Suppression of hepatitis B virus (HBV) DNA is more potent, and occurrence of resistant strain is rare with entecavir than lamivudine, but whether these merits result in a more favourable outcome in HBV-related decompensated cirrhosis ...

Aurobindo Bags USFDA Nod For Lamivudine & Zidovudine Tabs - Top News India

Aurobindo Pharma Limited has pocketed final authorization from the US Food and Drug Administration (FDA) to produce and sell lamivudine and zidovudine tabs USP 150/300mg (ANDA 202418). Hyderabad-based pharma major said that it is ready to launch the ...

Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - equitybulls.com

Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch. Lamivudine & Zidovudine ...

Aurobindo Pharma gets US FDA approval for lamivudine & zidovudine tabs - pharmabiz.com

Aurobindo Pharma Limited, Hyderabad-based pharma major, has received final approval from the US FDA to manufacture and market lamivudine and zidovudine tablets USP 150/300mg (ANDA 202418) and is ready for launch. Lamivudine and zidovudine tablets USP 150 ...

Lupin Launches Generic Combivir Tablets - RTT News

(RTTNews) - Pharmaceutical company Lupin Ltd. announced that its subsidiary Lupin Pharmaceuticals inc. had obtained final approval from US FDA for its Lamivudine and Zidovudine tablets, 150mg/ 300mg. The Mumbai-based company said it already commenced ...

Aurobindo gets USFDA approval for two tablets - Business Standard

Hyderabad-based pharmaceutical company Aurobindo Pharma limited (APL) on Wednesday stated that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Lamivudine and Zidovudine tablets. According to APL ...

South Africa exceeds 2007-11 treatment targets by 50% - Aidsmap

Crude estimates of numbers of public sector patients on treatment in each quarter were calculated according to lamivudine (3TC, Epivir) sales figures from Aspen Pharmacare, which supplied 80% of lamivudine to the public sector until recently. While they ...

Lupin report: New launches continue to fuel US growth - Stock Markets Review

Lupin has received approval and subsequently launched generic Lamivudine and Zidovudine Tablets (Brand name: Combivir; market size: US$275mn; Dosage: 150mg, 300mg; Indication: Antiretroviral) in the US. The company’s launch follows expiry of Teva’s six ...

Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019 - Yahoo Finance

504.3.6 Epivir-HBV (lamivudine) 524.3.7 Viread (tenovofir) 544.4 Key Takeaway 565 Hepatitis B Therapeutics - Pipeline Assessment 575.1 Overview 575.2 Strategic Pipeline Assessment 575.3 Hepatitis B Therapeutics - Pipeline Analysis by Clinical ...

FDA Advisory Committee Supports Approval of Gilead's Truvada for Reducing the Risk of Acquiring HIV - Phramalive.com

Truvada should not be co-administered with any other antiretroviral agents for HIV that contain emtricitabine or tenofovir disoproxil fumarate, nor should it be co-administered with products containing lamivudine. Do not administer with Hepsera.

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK